Ferrer, Marven D.
HRN: 28-01-27 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2025
CEFTRIAXONE 1G (VIAL)
10/27/2025
11/03/2025
IV
2g
OD
Tc Pmbo
Checking Final Appropriateness
10/27/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/27/2025
11/03/2025
IV
500mg
Q8
Tc Pmbo
Checking Final Appropriateness
11/02/2025
CEFTRIAXONE 1G (VIAL)
11/02/2025
11/04/2025
IV
2g
Od
Bowel Obstruction
Waiting Final Action